{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Beyond BCG: What Comes Next for Patients","description":"In this episode of Bladder Cancer Matters, host and survivor Rick Bangs sits down with ImmunityBio\u2019s Chief Medical Officer, Dr. Bobby Reddy, for a fascinating, hopeful look at the future of bladder cancer treatment. They unpack how next-generation immunotherapies like ANKTIVA\u2014paired with innovative approaches to BCG\u2014are reshaping care for patients, especially those with limited options, while also tackling real-world challenges like ongoing BCG shortages. Dr. Reddy breaks down the science in a way that\u2019s accessible, highlighting how activating the body\u2019s own immune system could lead to longer-lasting responses and even help patients avoid more invasive treatments. Tune in to this conversation about progress and possibility. ","author_name":"Bladder Cancer Matters","author_url":"http:\/\/bladdercancer.libsyn.com\/website","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/40826635\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/ef9a39\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/200693355"}